Assignee
CURIGIN CO LTD
KR·3 granted patents·6 pending applications·1 citations·filing 2018–2023
Top patents by PatentIndex Score
9 records- 0179US11149272B2Nucleic acid simultaneously inhibiting expression of mTOR gene and STAT3 geneCURIGIN CO LTD·Filed 2018·Granted Oct 19, 2021·1 cites·10 claims
- 0268US11634712B2Nucleic acid simultaneously inhibiting expression of mTOR gene and STAT3 geneCURIGIN CO LTD·Filed 2020·Granted Apr 25, 2023·0 cites·9 claims
- 0362US2025188426A1Adenovirus type 5/3 for detecting circulating tumor cellsCURIGIN CO LTD·Filed 2023·Application pending·0 cites
- 0458US2025382634A1Immune-cloaking antitumor adenovirusCURIGIN CO LTD·Filed 2022·Application pending·0 cites
- 0550US2024158789A1Nucleic acids simultaneously inhibiting expression of c-met gene and pd-l1 geneCURIGIN CO LTD·Filed 2022·Application pending·0 cites
- 0649US2023127169A1Structure of oncolytic virus comprising bispecific nucleic acid moleculeCURIGIN CO LTD·Filed 2021·Application pending·0 cites
- 0742US2023405065A1Modified htert promoter for regulating cancer cell-specific gene expression and anti-tumor adenovirus containing sameCURIGIN CO LTD·Filed 2021·Application pending·0 cites
- 0842US2024153581A1Method, device, computer program and computer-readable recording medium for designing nucleic acid moleculesCURIGIN CO LTD·Filed 2020·Application pending·0 cites
- 0940US10947542B2Nucleic acid simultaneously inhibiting expression of AR gene and mTOR geneCURIGIN CO LTD·Filed 2018·Granted Mar 16, 2021·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when CURIGIN CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →